13F Holdings
中文EN

BMGL Basel Medical Group Ltd IFRS Annual reports only

Services-Offices & Clinics of Doctors of Medicine · Nasdaq · SEC CIK 2004489 · Reporting currency SGD · Fiscal year ends 06/30

Financial factors as of 2025-06-30 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY12.6%
TTM net income YoY-613.1%
TTM EPS YoY-538.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin-94.0%
FCF margin-40.6%
EBITDA margin—

Returns

ROE-163.7%
ROA-60.8%
ROIC (approx.)—
Asset turnover0.65x

Leverage & solvency

Liabilities / assets70.9%
Debt / equity1.48x
Current ratio1.31x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.38x
Accruals ratio-37.7%
Payout ratio—
Capex / revenue4.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Unit: SGD FY20252025-06-30FY20242024-06-30
Income statement
Revenue11.32M10.05M
Interest expense203,948176,238
Pretax income-11.05M2.40M
Income tax-417,393331,761
Net income-10.64M2.07M
EPS (basic)-0.640.13
EPS (diluted)-0.570.13
Weighted avg. shares (diluted)18.79M16.25M
Balance sheet
Cash & equivalents3.04M1.95M
Receivables9.49M2.01M
Inventory489,06272,030
Current assets13.29M16.17M
PP&E, netmay include right-of-use assets (IFRS)388,65734,513
Goodwill10.35M—
Total assets18.68M16.31M
Current liabilities10.16M7.16M
Short-term debt5.08M4.29M
Long-term debt2.96M1.58M
Total debt8.03M5.87M
Total liabilities13.24M8.75M
Shareholders' equity5.43M7.56M
Net debt4.99M3.92M
Cash flow statement
Operating cash flow-4.04M2.51M
Capital expenditure556,9407,920
Free cash flow-4.60M2.50M
Investing cash flow-10.90M-7,920
Financing cash flow16.50M-1.77M

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· This company does not report gross profit in XBRL.

· Amounts are in the company's reporting currency, SGD, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.